-
FULC Stock Falls as Muscle Disorder Study Misses Primary Goal
2024 Sep 13, 2:42pm | 658Shares of Fulcrum Therapeutics, Inc. (NASDAQ: FULC) plunged 61.1% on Sept. 12 after the company announced disappointing top-line data from the phase III REACH study, which evaluated its pipeline candidate, losmapimod, for treating patients with facioscapulohumeral muscular dystrophy (FSHD), a rare...
-
Affirm's Survey Reveals 0% APR Option Impact, CEO Outlines Growth Plan
2024 Sep 13, 2:20pm | 560Affirm Holdings, Inc. (NASDAQ: AFRM) recently unveiled results from its latest survey, highlighting consumer shopping behaviors before the holiday season of 2024. The study of 2,000 Americans unveiled how the 0% annual percentage rate (APR) options would influence consumers while making...
-
Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance?
2024 Sep 13, 11:46am | 895QIAGEN N.V. (NYSE: QGEN) announced the expansion of its strategic partnership with Bio-Manguinhos/Fiocruz, a leading vaccines and diagnostics supplier to the Brazilian Ministry of Health. Initiated in 2009, the expanded collaboration allows Bio-Manguinhos to launch an advanced PCR (Polymerase...
-
RH Shares Leap On Heels Of Q2 Revenue Report, But Analysts Say Management Is 'Too Optimistic'
2024 Sep 13, 10:13am | 665Shares of RH (NYSE:RH) climbed 23.6% at last check Friday, after the company reported upbeat second-quarter results. The company, also known as Restoration Hardware, reported its results amid an exciting earnings season. Here are some key analyst takeaways. Bank of America analyst Curtis Nagle...
-
Adobe Stock Tanks On Disappointing Q4 Guidance: Why These Analysts Say Reaction Was 'Overblown'
2024 Sep 13, 9:39am | 1096Shares of Adobe Inc (NASDAQ:ADBE) tanked in early trading on Friday, even after the company reported upbeat fiscal third-quarter results. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. RBC Capital Markets analyst Matthew Swanson maintained...
-
Solventum Shares May Gain on the Launch of Its New V.A.C Therapy
2024 Sep 12, 12:28pm | 877Solventum Corporation (NYSE: SOLV) recently announced the launch of the V.A.C. Peel and Place Dressing, an integrated dressing and drape that can be applied quickly and worn by patients for up to seven days. Traditional dressings for negative pressure wound therapy typically take more...
-
Sanara Stock Gains From New US Distribution Deal With ChemoMouthPiece
2024 Sep 12, 10:34am | 884Sanara MedTech Inc. (NASDAQ: SMTI), along with InfuSystem Inc., recently entered into an exclusive U.S. distribution agreement with ChemoMouthpiece, LLC. Sanara will execute the terms of the agreement with the help of SI Healthcare Technologies (SI Technologies), which is a 50/50 joint venture...
-
Owens & Minor Stock to Gain From New Collaboration With Google Cloud
2024 Sep 12, 10:07am | 826Owens & Minor, Inc. (NYSE: OMI) has announced a partnership with Google Cloud, owned by the parent holding company, Alphabet to enhance the existing capabilities of its cloud-based clinical inventory management system, QSight. The collaboration will combine the company's expertise in...
-
Here's Why You Should Buy Kronos Worldwide Stock Right Now
2024 Sep 11, 2:00pm | 835Kronos Worldwide, Inc. (NYSE: KRO) is expected to benefit from higher demand for titanium dioxide (TiO2) and easing pricing pressure this year. Cost-reduction initiatives are also expected to support margins. We are positive about KRO's prospects and believe that the time is right for you to...
-
Paragon 28 Stock Gains From the Latest Launch of Its Right-Angle Drill
2024 Sep 11, 1:33pm | 806Paragon 28, Inc. (NYSE: FNA) recently introduced a novel Right-Angle Drill, designed to improve tibia preparation prior to the implantation of the APEX 3D tibia. The Right-Angle Drill will be an addition to the APEX 3D Total Ankle Replacement System. This recent advancement to the APEX 3D...
-
Reasons to Retain ResMed Stock in Your Portfolio for Now
2024 Sep 11, 1:27pm | 834ResMed Inc.'s (NYSE: RMD) growth is backed by its impressive global Mask sales growth. Of late, the company has been experiencing increased Device sales, reflecting the ongoing combined availability of AirSense 10 and AirSense 11 sleep devices. However, concerns loom over ResMed's...
-
Glaukos Stocks Rides on Strong Product Demand Amid Competition
2024 Sep 11, 1:20pm | 1284Glaukos Corporation (NYSE: GKOS) is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. The strength in the iStent product line and solid execution across its global glaucoma and Corneal Health franchises...
-
Dave & Buster's Analysts See Upside In 'Challenging Environment' After Q2 Earnings Beat
2024 Sep 11, 9:41am | 496Shares of Dave & Buster’s Entertainment Inc (NASDAQ:PLAY) climbed in early trading on Wednesday, after the company reported upbeat second-quarter results. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. BMO Capital Markets On Dave...
-
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
2024 Sep 10, 2:42pm | 819Shares of The Cigna Group (NYSE: CI) have gained 25.6% in the past year compared with the industry's 18.2% growth. The Medical sector and the S&P 500 composite index have rallied 9.3% and 21.2%, respectively, in the same time frame. CI has been well-poised for growth on the back of a sound...
-
Here's Why You Should Hold Onto Air Products Stock for Now
2024 Sep 10, 1:36pm | 749Air Products and Chemicals, Inc. (NYSE: APD) is expected to gain from its project investments, productivity actions and new business deals amid the softness in China and Europe. The company's shares have lost 9.6% over a year compared with a 10.6% decline of its industry. Image Source: Zacks...
Coverage of Earnings Beats.